Although largely unregulated, there is much provider consensus and best practice around a safe and effective Ibogaine treatment model to help evaluate an Ibogaine treatment center. This model is based or aligned closely with the clinical guidelines published by the Global Ibogaine Therapy Alliance (GITA). Although a detailed discussion of the GITA guidelines is beyond the scope here, a synopsis of a GITA-based treatment model includes:
- Assessing the patient’s specific condition, drug use, medical history and suitability for Ibogaine treatment.
- Exhaustive pre-screening and medical tests with a focus on identifying any risks or conditions that the patient would be exposed to. Note: It is possible that patient might be denied treatment based on the outcome of these tests if unacceptable risk is identified.
- Physical and psychological preparation for treatment
- Administration of Ibogaine hydrochloride of suitable dosage in a clinical medical environment by qualified medical personnel
- Patient monitoring in a clinical medical environment by qualified medical personnel. Note: This should include personnel and equipment capable of responding to a medical emergency.
Planning for a suitable Ibogaine Aftercare program with support services after leaving detox as the patient recovers physically and begins to integrate their Ibogaine treatment experience. This may include therapeutic psychological or psychotherapy services from qualified professionals.
Although this synopsis is far from exhaustive or detailed it’s intended to describe a checklist for a minimally acceptable program from a qualified treatment provider. Typical duration would range from 5 to 7 days. Significant departure from this general model or duration would be a cause for concern.